Come up with a name for your new list and we'll add to it:
InnoPharma raised a round of funding on November 14, 2013. Investors include
Athyrium Capital Management.
InnoPharma is a sterile product development company, focused on developing complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms. The Company has a…